about
New perspectives for the treatment of cholestasis: lessons from basic science applied clinically.FXR signaling in metabolic disease.Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits.The farnesoid X receptor regulates transcription of 3beta-hydroxysteroid dehydrogenase type 2 in human adrenal cells.Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.Epigenomic regulation of bile acid metabolism: emerging role of transcriptional cofactors.Blinded evaluation of farnesoid X receptor (FXR) ligands binding using molecular docking and free energy calculations.microRNA-192 suppresses the expression of the farnesoid X receptor.Ethanolic extract of Commiphora mukul gum resin attenuates streptozotocin-induced alterations in carbohydrate and lipid metabolism in rats.Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.Targeting the Farnesoid X Receptor in Patients With Cholestatic Liver Disease.Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.Increased levels of the novel hepatokine fetuin B in patients with intrahepatic cholestasis of pregnancy.The appetite regulatory effect of guggulsterones in rats: a repertoire of plasma hormones and neurotransmitters.It's all about bile.
P2860
Q35741546-510FA73B-57D3-44C3-94D1-B72DD2F0DFCAQ37006382-36343F34-1B19-47F9-A184-337905904009Q37031592-A15B7822-AD8B-49FB-A4B8-EF442D05F1DEQ37184702-BBC733F2-DA17-4C99-BE15-618CCC3BF630Q37200971-B52368EC-B386-4272-8A25-D8265BC980BCQ38009566-96BEACC8-E63D-4752-A7F5-B3C66839DE54Q38597033-072749B2-FA2D-4400-AA75-5333CF69C7A6Q38778196-8BC0D878-1C5E-49FA-A839-1CB95716152FQ39253220-C51D04E4-E5D3-4A12-BAEA-718B416DE154Q39881956-13440040-F05B-482D-B036-96A6941660D8Q41862942-B5638150-0368-4A7B-8296-3824B58FFF0CQ43040953-F922B192-F092-4E27-98B0-D7882D011327Q47302008-22EA9B0E-DAA7-42E0-BDDC-B823FEFCFD40Q47624137-1FBD087A-A2B0-4857-9496-F542960A1E30Q48493435-4216568C-9729-4B62-A5B4-D190C5D6718C
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
FXR: a target for cholestatic syndromes?
@ast
FXR: a target for cholestatic syndromes?
@en
type
label
FXR: a target for cholestatic syndromes?
@ast
FXR: a target for cholestatic syndromes?
@en
prefLabel
FXR: a target for cholestatic syndromes?
@ast
FXR: a target for cholestatic syndromes?
@en
P2860
P1476
FXR: a target for cholestatic syndromes?
@en
P2093
James L Boyer
Shi-Ying Cai
P2860
P304
P356
10.1517/14728222.10.3.409
P407
P577
2006-06-01T00:00:00Z